1-22638945-A-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_015991.4(C1QA):​c.276A>G​(p.Gly92Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.429 in 1,600,412 control chromosomes in the GnomAD database, including 154,959 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 21743 hom., cov: 33)
Exomes 𝑓: 0.42 ( 133216 hom. )

Consequence

C1QA
NM_015991.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.733

Publications

62 publications found
Variant links:
Genes affected
C1QA (HGNC:1241): (complement C1q A chain) This gene encodes the A-chain polypeptide of serum complement subcomponent C1q, which associates with C1r and C1s to yield the first component of the serum complement system. C1q deficiency is associated with lupus erythematosus and glomerulonephritis. C1q is composed of 18 polypeptide chains which include 6 A-chains, 6 B-chains, and 6 C-chains. Each chain contains an N-terminal collagen-like region and a C-terminal C1q globular domain. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
C1QA Gene-Disease associations (from GenCC):
  • C1Q deficiency
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.061).
BP6
Variant 1-22638945-A-G is Benign according to our data. Variant chr1-22638945-A-G is described in ClinVar as Benign. ClinVar VariationId is 1167796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.733 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C1QANM_015991.4 linkc.276A>G p.Gly92Gly synonymous_variant Exon 3 of 3 ENST00000374642.8 NP_057075.1 P02745A0A024RAG6
C1QANM_001347465.2 linkc.276A>G p.Gly92Gly synonymous_variant Exon 3 of 3 NP_001334394.1 P02745A0A024RAG6
C1QANM_001347466.2 linkc.276A>G p.Gly92Gly synonymous_variant Exon 3 of 3 NP_001334395.1 P02745A0A024RAG6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C1QAENST00000374642.8 linkc.276A>G p.Gly92Gly synonymous_variant Exon 3 of 3 1 NM_015991.4 ENSP00000363773.3 P02745
ENSG00000289692ENST00000695747.1 linkc.276A>G p.Gly92Gly synonymous_variant Exon 3 of 5 ENSP00000512140.1 A0A8Q3SI62

Frequencies

GnomAD3 genomes
AF:
0.512
AC:
77782
AN:
151976
Hom.:
21690
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.732
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.532
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.590
Gnomad SAS
AF:
0.607
Gnomad FIN
AF:
0.418
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.385
Gnomad OTH
AF:
0.487
GnomAD2 exomes
AF:
0.486
AC:
107980
AN:
222358
AF XY:
0.479
show subpopulations
Gnomad AFR exome
AF:
0.737
Gnomad AMR exome
AF:
0.624
Gnomad ASJ exome
AF:
0.372
Gnomad EAS exome
AF:
0.592
Gnomad FIN exome
AF:
0.425
Gnomad NFE exome
AF:
0.386
Gnomad OTH exome
AF:
0.455
GnomAD4 exome
AF:
0.420
AC:
608384
AN:
1448318
Hom.:
133216
Cov.:
83
AF XY:
0.423
AC XY:
304269
AN XY:
719314
show subpopulations
African (AFR)
AF:
0.747
AC:
24849
AN:
33248
American (AMR)
AF:
0.615
AC:
25837
AN:
42036
Ashkenazi Jewish (ASJ)
AF:
0.377
AC:
9721
AN:
25802
East Asian (EAS)
AF:
0.601
AC:
23510
AN:
39104
South Asian (SAS)
AF:
0.583
AC:
49295
AN:
84498
European-Finnish (FIN)
AF:
0.419
AC:
21898
AN:
52298
Middle Eastern (MID)
AF:
0.390
AC:
2235
AN:
5724
European-Non Finnish (NFE)
AF:
0.384
AC:
424774
AN:
1105760
Other (OTH)
AF:
0.439
AC:
26265
AN:
59848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
25262
50524
75785
101047
126309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13710
27420
41130
54840
68550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.512
AC:
77891
AN:
152094
Hom.:
21743
Cov.:
33
AF XY:
0.518
AC XY:
38477
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.732
AC:
30410
AN:
41518
American (AMR)
AF:
0.532
AC:
8140
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1326
AN:
3468
East Asian (EAS)
AF:
0.590
AC:
3038
AN:
5152
South Asian (SAS)
AF:
0.607
AC:
2924
AN:
4820
European-Finnish (FIN)
AF:
0.418
AC:
4425
AN:
10576
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.385
AC:
26158
AN:
67950
Other (OTH)
AF:
0.492
AC:
1041
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1819
3637
5456
7274
9093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.424
Hom.:
62053
Bravo
AF:
0.530
Asia WGS
AF:
0.630
AC:
2188
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 77% of patients studied by a panel of primary immunodeficiencies. Number of patients: 68. Only high quality variants are reported. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26017655, 12630757, 16465510, 16086173, 20332777) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

C1Q deficiency Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.3
DANN
Benign
0.41
PhyloP100
-0.73
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs172378; hg19: chr1-22965438; COSMIC: COSV65889459; COSMIC: COSV65889459; API